Serge Belanger
Stock Analyst at Needham
(4.44)
# 323
Out of 4,974 analysts
374
Total ratings
55.27%
Success rate
17.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYTK Cytokinetics | Reiterates: Buy | $72 | $53.01 | +35.82% | 24 | Sep 2, 2025 | |
| OCS Oculis Holding AG | Initiates: Buy | $36 | $17.16 | +109.79% | 1 | Aug 27, 2025 | |
| OMER Omeros | Reiterates: Hold | n/a | $4.17 | - | 8 | Aug 15, 2025 | |
| AMPH Amphastar Pharmaceuticals | Upgrades: Buy | $36 | $29.43 | +22.32% | 6 | Aug 12, 2025 | |
| LQDA Liquidia | Maintains: Buy | $32 → $36 | $28.85 | +24.78% | 33 | Aug 12, 2025 | |
| HRTX Heron Therapeutics | Maintains: Buy | $4 → $3 | $1.31 | +129.01% | 23 | Aug 8, 2025 | |
| TRVI Trevi Therapeutics | Maintains: Buy | $24 → $22 | $7.01 | +213.84% | 22 | Aug 8, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $20 → $22 | $17.15 | +28.28% | 22 | Aug 7, 2025 | |
| VRDN Viridian Therapeutics | Maintains: Buy | $36 → $34 | $18.72 | +81.62% | 18 | Aug 6, 2025 | |
| EOLS Evolus | Downgrades: Hold | $22 | $7.66 | +187.21% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $13.60 | +10.29% | 4 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 | $8.27 | +105.56% | 16 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $3 | $0.35 | +767.05% | 16 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $12.40 | +61.29% | 18 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $27.00 | +48.15% | 9 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $5.11 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $66 | $59.44 | +11.04% | 13 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $55 | $39.18 | +40.38% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $26.45 | +13.42% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $2.68 | +49.25% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $38.37 | +19.89% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $28 | $15.82 | +76.99% | 20 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.96 | - | 1 | Mar 31, 2022 |
Cytokinetics
Sep 2, 2025
Reiterates: Buy
Price Target: $72
Current: $53.01
Upside: +35.82%
Oculis Holding AG
Aug 27, 2025
Initiates: Buy
Price Target: $36
Current: $17.16
Upside: +109.79%
Omeros
Aug 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $4.17
Upside: -
Amphastar Pharmaceuticals
Aug 12, 2025
Upgrades: Buy
Price Target: $36
Current: $29.43
Upside: +22.32%
Liquidia
Aug 12, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $28.85
Upside: +24.78%
Heron Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.31
Upside: +129.01%
Trevi Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $7.01
Upside: +213.84%
Arcutis Biotherapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $17.15
Upside: +28.28%
Viridian Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $18.72
Upside: +81.62%
Evolus
Aug 6, 2025
Downgrades: Hold
Price Target: $22
Current: $7.66
Upside: +187.21%
Aug 5, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $13.60
Upside: +10.29%
Aug 4, 2025
Maintains: Buy
Price Target: $17
Current: $8.27
Upside: +105.56%
Jul 17, 2025
Downgrades: Hold
Price Target: $3
Current: $0.35
Upside: +767.05%
Jun 24, 2025
Maintains: Buy
Price Target: $15 → $20
Current: $12.40
Upside: +61.29%
Jun 12, 2025
Reiterates: Buy
Price Target: $40
Current: $27.00
Upside: +48.15%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.11
Upside: -
May 13, 2025
Reiterates: Buy
Price Target: $66
Current: $59.44
Upside: +11.04%
May 13, 2025
Maintains: Buy
Price Target: $60 → $55
Current: $39.18
Upside: +40.38%
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $26.45
Upside: +13.42%
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $2.68
Upside: +49.25%
Apr 9, 2025
Reiterates: Buy
Price Target: $46
Current: $38.37
Upside: +19.89%
Apr 8, 2025
Reiterates: Buy
Price Target: $28
Current: $15.82
Upside: +76.99%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.96
Upside: -